Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunome Inc. logo

Chief Medical Officer Lechleider Robert was granted 54,000 shares, increasing direct ownership by 342% to 69,805 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMNM· Immunome Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.